TABLE IV.

Results of Cost-Effectiveness Analysis for Baseline Models^*

	Net Cost ($)	Difference in Cost ($)	Effectiveness (QALY)	Difference in QALY	ICER
Health-care perspective
Hook plate	5,372	+4,952	0.86	–0.09	Dominated by NO
Suture button	3,798	+3,378	0.91	–0.04	Dominated by NO
Allograft	4,742	+4,322	0.92	–0.03	Dominated by NO
Nonoperative	420	Ref.	0.95	Ref.	Ref.
Societal perspective
Hook plate	11,520	+6,192	0.86	–0.06	Dominated by AG
Suture button	5,635	+307	0.91	–0.01	Dominated by AG
Allograft	5,328	Ref.	0.92	Ref.	Ref.
Nonoperative	5,640	+312	0.95	+0.03	$13,751/QALY gained
Combined perspective
Hook plate	16,892	+10,832	0.86	–0.09	Dominated by NO
Suture button	9,433	+3,373	0.91	–0.04	Dominated by NO
Allograft	10,070	+4,010	0.92	–0.03	Dominated by NO
Nonoperative	6,060	Ref.	0.95	Ref.	Ref.

^*QALY = quality-adjusted life-year, ICER = incremental cost-effectiveness ratio, NO = nonoperative, and AG = allograft.